Cas 941678-49-5 Ruxolitinib, Factory price Ruxolitinib

Message

$60.00

Have chosenThere are no options selected.

Start To Order

Add To Cart Successfully!

SEND INQUIRY
Cas 941678-49-5 Ruxolitinib, Factory price Ruxolitinib
Cas 941678-49-5 Ruxolitinib, Factory price Ruxolitinib
Cas 941678-49-5 Ruxolitinib, Factory price Ruxolitinib
Cas 941678-49-5 Ruxolitinib, Factory price Ruxolitinib
Cas 941678-49-5 Ruxolitinib, Factory price Ruxolitinib
Cas 941678-49-5 Ruxolitinib, Factory price Ruxolitinib
Cas 941678-49-5 Ruxolitinib, Factory price Ruxolitinib

Cas 941678-49-5 Ruxolitinib, Factory price Ruxolitinib

  • Item No.ruxolitinib
    MOQ1 Gram
Tag  sourcing
Add Request About This Product
Max file 5MB each
If lager file please send us email

Quantity:

From $60.0055.00 / Gram
$60.00
You save $ -60.00
Trade Assuranceprotects your orders
Payments:
Order protection service which protects online orders when payment is made through Alibaba's Trade Assurance. Learn More
Trade Assurance reduces risks in:
Product Quality On-Time Shipment

If you have your own design, please contact us, there will have a professional customer service to communicate with you.

Don't have your files right now?No worries, Check out our art tips for more information.

If over 500pcs, mass production will start until pre-production sample has been approved.

Est. 7 days production

Quick Details
Product name Ruxolitinib
Appearance White Powder
Place of Origin CN;SHN
Usage Animal Pharmaceuticals
Brand Name xigema
certificateISO
Model Number ruxolitinib
Application Pharmaceutical intermediates
CAS941678-49-5
ColorWhite
NameRuxolitinib
Assay HPLC 99%
Shelf Life 2 Years
Grade Standard Medicine Grade
Type Antibiotic and Antimicrobial Agents
CAS No. 941678-49-5
Other Names Ruxolitinib
MFC17H18N6
EINECS No. N/A
Purity99%min
Grade Medicine Grade

Packaging & Delivery

Selling Units:
Gram
Lead Time:
Quantity(Gram)1 - 1000>1000
Est. Time(days)3To be negotiated
Product Description

 

Specifciation:

                             1.Competitive price
                             2.Fast Delivery Within 2 days
                             3.SGS , BV, GMP,ISO approve
                             4.Professional factory

                    

3.jpg 

Ruxolitinib is a drug for the treatment of intermediate or high-risk myelofibrosis, a type of myeloproliferative disorder that affects the bone marrow, and for polycythemia vera (PCV) when there has been an inadequate response to or intolerance of hydroxyurea.

Analysis

5.jpg 

Items

Specifications

Results

Appearance

White to whitish crystal powder

Conforms

Loss on drying

NMT 0.5%

0.33%

Residue on ignition

NMT 0.1%

Conforms

Heavy metal

NMT 20ppm

Conforms

Assay (HPLC)

NLT 99.5%

99.77%

Related substances

NMT 0.5%

0.23%

Single impurity

NMT 0.1%

0.07%

Conclusion: Complies to the Enterprise standard  

Packaging & Shipping

 

 

package.png 

Our Services

456.jpg 

Company Information

 

Qingdao xigema Chemical Co.,Ltd is a global chemical industry manufacturers and suppliers of pharmaceuticals 

and intermediates, food and feed additives, herbal extracts, agrochemicals and fine chemicals etc.

The aim of xigema is a quality policy that "Elements in the system all have been satisfied, Personnel has been trained; Every batch of material is checked, Each procedure guarantees the quality; Every bag of our products is top grade, Service is thoughtful all the time, quality and reputation to increase market share and promote enterprise development. The quality, colors and forms of our products have reached a high level in related chemical industry, which relies on characteristic and advanced processing technology and it has gained a high and reliable reputation from customers at both quality and services.

xigema has become the "Top 500 Chinese manufacturing companies","Top 20 of global chemical sales".xigema has 21 subsidiaries and holding companies.

33.jpg

teams.jpgREPUTION.jpg 

FAQ

 

No need register, just fill in contact info below, we will reply you within 24 hours!

Enter the code in the box below: